as 11-21-2024 11:37am EST
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
Founded: | 2003 | Country: | United States |
Employees: | N/A | City: | SAN JOSE |
Market Cap: | 31.8M | IPO Year: | 2020 |
Target Price: | $4.38 | AVG Volume (30 days): | 1.0M |
Analyst Decision: | Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.75 | EPS Growth: | N/A |
52 Week Low/High: | $0.43 - $6.37 | Next Earning Date: | 11-06-2024 |
Revenue: | $114,729,000 | Revenue Growth: | -13.00% |
Revenue Growth (this year): | -11.85% | Revenue Growth (next year): | 11.81% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Trigg Leslie | OM | Chair and CEO | Nov 15 '24 | Sell | $0.80 | 5,645 | $4,516.00 | 904,851 | |
Brottem John L. | OM | General Counsel | Nov 15 '24 | Sell | $0.80 | 3,203 | $2,562.40 | 227,092 |
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
Insider Monkey
10 days ago
Simply Wall St.
12 days ago
GuruFocus.com
14 days ago
Zacks
15 days ago
GlobeNewswire
15 days ago
GuruFocus.com
16 days ago
GlobeNewswire
a month ago
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.